Clinician Investigator Program, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, Keenan Research Centre in the Li Ka Shing Knowledge Institute at St. Michael's Hospital, Toronto, Ontario, Canada; Platform of Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Department of Surgery, Keenan Research Centre in the Li Ka Shing Knowledge Institute at St. Michael's Hospital, Toronto, Ontario, Canada; Interdivisional Department of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
J Surg Res. 2014 Mar;187(1):43-52. doi: 10.1016/j.jss.2013.09.035. Epub 2013 Oct 7.
South Asian ethnicity is an independent risk factor for mortality after coronary artery bypass. We tested the hypothesis that this risk results from a greater inflammatory response to cardiopulmonary bypass (CPB).
This was a single-site prospective cohort study. We compared the inflammatory response to CPB in 20 Caucasians and 17 South Asians undergoing isolated coronary artery bypass grafting surgery.
Plasma levels of proinflammatory cytokines (interleukin [IL]-6, IL-8, IL-12, interferon gamma, and tumor necrosis factor) and anti-inflammatory mediators (IL-10 and soluble TNF receptor I) were measured. The Toll-like receptor (TLR) signaling pathway was examined in peripheral blood monocytes by flow cytometry, measuring surface expression of TLR2, TLR4, and coreceptor CD14 and activation of downstream messenger molecules (interleukin-1 receptor-associated kinase 4, nuclear factor kappa from B cells (NF-κB), c-Jun amino-terminal kinase, p38 mitogen-activated protein kinase, and Protein Kinase B). South Asians had persistently higher plasma levels of IL-6 and exhibited increased TLR signaling through the p38 mitogen-activated protein kinase and Protein Kinase B pathways in inflammatory monocytes after CPB. This increased inflammatory response was paralleled clinically by a higher sequential organ failure assessment score (5.1 ± 1.4 versus 1.5 ± 1.6, P = 0.027) and prolonged cardiovascular system failure (23.5% versus 0%) 48 h after CPB.
South Asians develop an exacerbated systemic inflammatory response after CPB, which may contribute to the higher morbidity and mortality associated with coronary artery bypass in this population. These patients may benefit from targeted anti-inflammatory therapies designed to mitigate the adverse consequences resulting from this response.
南亚族裔是冠状动脉旁路移植术后死亡的独立危险因素。我们检验了这样一个假设,即这种风险源自于对体外循环(CPB)更大的炎症反应。
这是一项单中心前瞻性队列研究。我们比较了 20 名高加索人和 17 名南亚人在接受单纯冠状动脉旁路移植术时对 CPB 的炎症反应。
测定了促炎细胞因子(白细胞介素[IL]-6、IL-8、IL-12、干扰素γ和肿瘤坏死因子)和抗炎介质(IL-10 和可溶性 TNF 受体 I)的血浆水平。通过流式细胞术检测外周血单核细胞中的 Toll 样受体(TLR)信号通路,测量 TLR2、TLR4 和共受体 CD14 的表面表达以及下游信使分子(白细胞介素 1 受体相关激酶 4、B 细胞核因子 kappa(NF-κB)、c-Jun 氨基末端激酶、p38 丝裂原活化蛋白激酶和蛋白激酶 B)的激活。南亚人在 CPB 后,IL-6 的血浆水平持续升高,并表现出炎症单核细胞中 p38 丝裂原活化蛋白激酶和蛋白激酶 B 途径的 TLR 信号转导增加。这种炎症反应的增加在临床上表现为序贯器官衰竭评估评分较高(5.1 ± 1.4 比 1.5 ± 1.6,P = 0.027)和 CPB 后 48 小时心血管系统衰竭延长(23.5%比 0%)。
南亚人在 CPB 后会产生更严重的全身炎症反应,这可能导致该人群冠状动脉旁路移植术后发病率和死亡率较高。这些患者可能受益于旨在减轻这种反应不良后果的靶向抗炎治疗。